Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HLA-B Antigens | 1 | 2005 | 30 | 0.250 |
Why?
|
| Immunologic Factors | 1 | 2005 | 179 | 0.220 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2005 | 98 | 0.170 |
Why?
|
| Antigen Presentation | 2 | 2005 | 107 | 0.110 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2003 | 12 | 0.110 |
Why?
|
| Conserved Sequence | 2 | 2003 | 293 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2006 | 2702 | 0.100 |
Why?
|
| Phylogeny | 4 | 2005 | 685 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2004 | 805 | 0.080 |
Why?
|
| Bacterial Proteins | 2 | 2006 | 876 | 0.080 |
Why?
|
| Evolution, Molecular | 2 | 2003 | 670 | 0.080 |
Why?
|
| Molecular Sequence Data | 5 | 2006 | 3888 | 0.080 |
Why?
|
| Superantigens | 1 | 2006 | 20 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 94 | 0.070 |
Why?
|
| Enterotoxins | 1 | 2006 | 83 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 138 | 0.070 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 38 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 234 | 0.060 |
Why?
|
| Bacterial Toxins | 1 | 2006 | 176 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 2060 | 0.060 |
Why?
|
| Proteome | 1 | 2006 | 233 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2004 | 23 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2005 | 172 | 0.060 |
Why?
|
| HLA Antigens | 1 | 2005 | 243 | 0.060 |
Why?
|
| Sigmodontinae | 1 | 2003 | 42 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 79 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2005 | 374 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2003 | 285 | 0.050 |
Why?
|
| Multigene Family | 1 | 2002 | 299 | 0.050 |
Why?
|
| Peptides | 1 | 2005 | 799 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 415 | 0.040 |
Why?
|
| Lung | 1 | 2006 | 1484 | 0.040 |
Why?
|
| Animals | 7 | 2006 | 33923 | 0.030 |
Why?
|
| Protein Binding | 3 | 2003 | 1738 | 0.030 |
Why?
|
| Peromyscus | 2 | 2003 | 4 | 0.030 |
Why?
|
| Cytochrome b Group | 2 | 2003 | 5 | 0.030 |
Why?
|
| Muridae | 2 | 2003 | 16 | 0.030 |
Why?
|
| Rats | 3 | 2003 | 3665 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 658 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 390 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 2 | 2004 | 217 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2006 | 4392 | 0.020 |
Why?
|
| Mice | 5 | 2006 | 17647 | 0.020 |
Why?
|
| Binding Sites | 2 | 2004 | 1294 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2006 | 6 | 0.020 |
Why?
|
| Calgranulin B | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cell Migration Inhibition | 1 | 2006 | 10 | 0.020 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2006 | 10 | 0.020 |
Why?
|
| Lectins | 1 | 2006 | 49 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 105 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2006 | 46 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 61 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 156 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 158 | 0.020 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2006 | 52 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2006 | 42 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 284 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2006 | 187 | 0.020 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2006 | 93 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 209 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2006 | 395 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 29 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 79 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 95 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 2003 | 27 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2003 | 44 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 198 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2003 | 35 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 129 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2003 | 106 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 318 | 0.010 |
Why?
|
| Phenylalanine | 1 | 2003 | 122 | 0.010 |
Why?
|
| Biosensing Techniques | 1 | 2003 | 50 | 0.010 |
Why?
|
| Tyrosine | 1 | 2003 | 166 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2003 | 150 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 287 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 303 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 535 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2003 | 359 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 623 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 793 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1073 | 0.010 |
Why?
|
| Humans | 4 | 2006 | 122971 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 1316 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 1076 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 1069 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 1009 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 805 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 1217 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 3782 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2003 | 653 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 2787 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1760 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 5794 | 0.010 |
Why?
|